H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA) Sep 30, 2024 07:26AM
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $20 at H.C. Wainwright Sep 23, 2024 06:35AM
US FDA approves Zevra's treatment for rare genetic disease Sep 20, 2024 10:14AM
H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA) Jul 10, 2024 08:29AM